Protection against infection is likely short-term, lasting less than six months, but protection against severe disease appears more robust, researchers with the U.K. Health Security Agency reported Friday. Specifically, the researchers found that right after the third shot of the Pfizer vaccine, protection against a symptomatic infection is pretty good. Two weeks after the shot, the booster cuts the risk by about 70%.